Papers: 10.1038/s41598-017-06685-z

https://doi.org/10.1038/s41598-017-06685-z

Glycoengineering of EphA4 Fc leads to a unique, long-acting and broad spectrum, Eph receptor therapeutic antagonist

Cited by: 11
Author(s): Cassandra L. Pegg, Leanne Cooper, Jing Zhao, Michael Gerometta, Fiona Smith, Michael W. Yeh, Perry F. Bartlett, Jeffrey J. Gorman, Andrew W. Boyd
Published: about 8 years ago

Software Mentions 1